| Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis (NCT04315480) | Università Politecnica delle Marche | 2020-03-12 |
| Orphan Indications for CD19 Redirected Autologous T Cells (NCT04276870) | Stephan Grupp MD PhD | 2020-03-12 |
| Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral (NCT04025567) | National Cancer Institute (NCI) | 2020-03-12 |
| A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations (NCT04094610) | Turning Point Therapeutics, Inc. | 2020-03-12 |
| Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma (NCT03930498) | Sun Yat-sen University | 2020-03-12 |
| A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC (NCT04309578) | Asan Medical Center | 2020-03-12 |
| Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue (NCT04144257) | Brigham and Women's Hospital | 2020-03-12 |
| Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance (NCT03943342) | Kerry Rogers | 2020-03-11 |
| Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) (NCT04307693) | Asan Medical Center | 2020-03-11 |
| Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS (NCT04128956) | University of Zurich | 2020-03-11 |
| Efficacy and Safety of Ustekinumab in Bullous Pemphigoid (NCT04117932) | CHU de Reims | 2020-03-11 |
| The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia (NCT04263454) | University of Alabama at Birmingham | 2020-03-11 |
| Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity (NCT04221256) | Burke Medical Research Institute | 2020-03-11 |
| Oral Immunotherapy for Peanut Allergic Patients (NCT04163562) | InnoUp Farma S.L. | 2020-03-11 |
| Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation (NCT04195256) | Naveen Poonai | 2020-03-11 |
| Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tumors (NCT04319224) | Jounce Therapeutics, Inc. | 2020-03-10 |
| Study of Infigratinib in Children With Achondroplasia (NCT04265651) | QED Therapeutics, a BridgeBio company | 2020-03-10 |
| Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma (NCT04154943) | Regeneron Pharmaceuticals | 2020-03-10 |
| A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) (NCT04225117) | Astellas Pharma Global Development, Inc. | 2020-03-10 |
| Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber) (NCT04209075) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2020-03-10 |
| Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia (NCT04428268) | Hospital Universitario Dr. Jose E. Gonzalez | 2020-03-10 |
| Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID) (NCT04296162) | Fudan University | 2020-03-10 |
| Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism (NCT03854266) | University of Aarhus | 2020-03-10 |
| Antisecretory Factor In Severe Traumatic Brain Injury (NCT04117672) | Peter Siesjö | 2020-03-10 |
| A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy (NCT04150575) | Shanghai Henlius Biotech | 2020-03-10 |
| Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis (NCT04413942) | Oneness Biotech Co., Ltd. | 2020-03-10 |
| Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis (NCT04313400) | Amytrx Therapeutics, Inc. | 2020-03-10 |
| Plasma Exchange With Albumin in AMN Patients (NCT04303416) | Pujol, Aurora, M.D. | 2020-03-09 |
| A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies (NCT03847649) | Canadian Cancer Trials Group | 2020-03-09 |
| Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET (NCT04385992) | IRCCS San Raffaele | 2020-03-09 |
| A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis (NCT02057159) | Immune Response BioPharma, Inc. | 2020-03-09 |
| Statin Adjunctive Therapy for TB (NCT03456102) | Johns Hopkins University | 2020-03-09 |
| A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions (NCT04242927) | First People's Hospital of Hangzhou | 2020-03-09 |
| A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis (NCT02149706) | Immune Response BioPharma, Inc. | 2020-03-09 |
| Evaluating the Efficacy of Dry Eye (DE) Disease Treatment Using Novel Tear Film Imager (TFI) (NCT04670263) | Adom Advanced Optical Technologies Ltd. | 2020-03-08 |
| Developing Oral LT3 Therapy for Heart Failure - HFpEF (NCT04111536) | University of Pennsylvania | 2020-03-08 |
| Belimumab With Rituximab for Primary Membranous Nephropathy (NCT03949855) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-03-06 |
| ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection (NCT04247542) | Acurx Pharmaceuticals Inc. | 2020-03-06 |
| Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma (NCT04644432) | Herlev and Gentofte Hospital | 2020-03-06 |
| Topical Crisaborole in Patients with Alopecia Areata (NCT04299503) | Tufts Medical Center | 2020-03-06 |
| IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma (NCT03795610) | Assuntina G. Sacco, MD | 2020-03-06 |
| Parent Telehealth Intervention for Children With Autism (NCT04501588) | Northwestern University | 2020-03-06 |
| Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement (NCT03701295) | National Cancer Institute (NCI) | 2020-03-06 |
| An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS) (NCT05217472) | AbbVie | 2020-03-06 |
| Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma (NCT04361331) | Shanghai Zhongshan Hospital | 2020-03-06 |
| Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer (NCT03936270) | Latin American Cooperative Oncology Group | 2020-03-05 |
| A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab (NCT04365387) | Galderma R&D | 2020-03-05 |
| Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer (NCT04243616) | Medical College of Wisconsin | 2020-03-05 |
| Effects of Platelet Rich Fibrin (PRF) in Treatment of Non-healing Sternum Wound After Open-heart Surgery (NCT03183973) | SCARM Institute, Tabriz, Iran | 2020-03-05 |
| Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (NCT04319900) | Beijing Chao Yang Hospital | 2020-03-05 |
| Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) (NCT04288102) | Beijing 302 Hospital | 2020-03-05 |
| A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use (NCT03145857) | AHS Cancer Control Alberta | 2020-03-05 |
| Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) (NCT04123379) | Icahn School of Medicine at Mount Sinai | 2020-03-05 |
| First-in-Human Study of ICT01 in Patients With Advanced Cancer (NCT04243499) | ImCheck Therapeutics, an Ipsen company | 2020-03-05 |
| A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer (NCT04186156) | Karus Therapeutics Limited | 2020-03-05 |
| CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer (NCT04220476) | Weill Medical College of Cornell University | 2020-03-04 |
| Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia. (NCT03968198) | University Hospital, Toulouse | 2020-03-04 |
| AG-120 in People With IDH1 Mutant Chondrosarcoma (NCT04278781) | Memorial Sloan Kettering Cancer Center | 2020-03-04 |
| Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer (NCT03324425) | Baylor Breast Care Center | 2020-03-04 |
| Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer (NCT04389151) | The First Affiliated Hospital of Xiamen University | 2020-03-04 |
| Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002) (NCT04220866) | Merck Sharp & Dohme LLC | 2020-03-04 |
| A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease (NCT04030962) | AbbVie | 2020-03-04 |
| Ma-Spore ALL 2020 Study (NCT06336395) | National University Hospital, Singapore | 2020-03-04 |
| Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma (NCT04205838) | Jonsson Comprehensive Cancer Center | 2020-03-04 |
| CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma (NCT04145700) | Eli Lilly and Company | 2020-03-04 |
| A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer (NCT04298086) | Memorial Sloan Kettering Cancer Center | 2020-03-04 |
| Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NCT04205552) | University Hospital, Essen | 2020-03-04 |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (NCT04276597) | Excel Diagnostics and Nuclear Oncology Center | 2020-03-04 |
| A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact (NCT03969992) | Aerogen Pharma Limited | 2020-03-04 |
| Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis (NCT04396756) | Pliant Therapeutics, Inc. | 2020-03-03 |
| Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer (NCT04262154) | Memorial Sloan Kettering Cancer Center | 2020-03-03 |
| Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement (NCT04256980) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-03-03 |
| Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects (NCT04324359) | Surface Ophthalmics, Inc. | 2020-03-03 |
| Open-label Extension Study of Brazikumab in Ulcerative Colitis (NCT04277546) | AstraZeneca | 2020-03-03 |
| Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH (NCT04202354) | Arrowhead Pharmaceuticals | 2020-03-03 |
| A Clinical Trial of PRAX-944 in Participants With Essential Tremor (NCT05021978) | Praxis Precision Medicines | 2020-03-03 |
| A Phase 2 Trial of OPC-64005 for Major Depressive Disorder (NCT04244253) | Otsuka Pharmaceutical Co., Ltd. | 2020-03-03 |
| Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer (NCT04117945) | Academic and Community Cancer Research United | 2020-03-03 |
| First-in-Human Study of BCX9930 in Healthy Volunteers and Patients With PNH (NCT04330534) | BioCryst Pharmaceuticals | 2020-03-03 |
| Lactoferrin + Vitamin E + Zinc for Hormonal Acne (NCT05151055) | United Laboratories | 2020-03-02 |
| Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (NCT04310930) | The University of Queensland | 2020-03-02 |
| Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) (NCT03896074) | Fondazione Ricerca Traslazionale | 2020-03-02 |
| Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes (NCT04262479) | Norwegian University of Science and Technology | 2020-03-02 |
| The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy (NCT05525156) | Muhimbili University of Health and Allied Sciences | 2020-03-02 |
| Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma (NCT05805943) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2020-03-02 |
| Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma (NCT04091750) | Georgetown University | 2020-03-02 |
| Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine (NCT04078022) | University of Maryland, Baltimore | 2020-03-02 |
| Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer (NCT04258657) | Beijing Friendship Hospital | 2020-03-01 |
| Cannabidiol for Anxiety (NCT04267679) | CB2 Insights | 2020-03-01 |
| T2DXcel Mobile Application (NCT03890900) | Montefiore Medical Center | 2020-03-01 |
| Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma (NCT04118855) | RenJi Hospital | 2020-03-01 |
| A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis (NCT04231292) | Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd | 2020-03-01 |
| Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only (NCT04148170) | Cairo University | 2020-03-01 |
| LYT-100 in Patients With BCRL (NCT04243837) | PureTech | 2020-03-01 |
| A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer (NCT04394598) | Fudan University | 2020-03-01 |
| Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib (NCT04565600) | Guangdong Provincial People's Hospital | 2020-03-01 |
| Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients (NCT03611985) | University of Florida | 2020-03-01 |
| Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma (NCT04795869) | Northwestern University | 2020-03-01 |
| Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer (NCT04296747) | Peking Union Medical College Hospital | 2020-03-01 |
| A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease (NCT04228666) | Hope Biosciences LLC | 2020-03-01 |